Epsilon M&A Deal Report - Omega Pharma
Transaction Multiples for the Valuation of Private Companies
Private Group led by Waterland Private Equity / Omega Pharma
No EMAT :
80657
Announced Date :
02/09/2011
Type :
P2P (Public to Private)
Deal Value :
Yes
Acquirer :
Private Group led by Waterland Private Equity
Target :
Omega Pharma
Country :
Belgium
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Founded in 1987, Omega Pharma is an OTC healthcare company . It develops and sells prescription-free health and personal care products to the pharmacies and other medical sectors. > Product mix...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 128
- Number of EMAT Reports / sub-sector « Personal Products » = 127
| Date | Acquirer | Target | Country | Multiples | See details |
| 06/08/2013 | STADA Arzneimittel | Thornton & Ross | United Kingdom | *** | 80590 |
| 30/09/2016 | Eurofins Scientific | Megalab | Spain | * | 80029 |
Source: Epsilon Research / EMAT
